Hypocretin-1 and GABA in the Pontine Reticular Formation Interact to Promote Wakefulness.
dc.contributor.author | Brevig, Holly N. | en_US |
dc.date.accessioned | 2010-08-27T15:18:16Z | |
dc.date.available | NO_RESTRICTION | en_US |
dc.date.available | 2010-08-27T15:18:16Z | |
dc.date.issued | 2010 | en_US |
dc.date.submitted | en_US | |
dc.identifier.uri | https://hdl.handle.net/2027.42/77843 | |
dc.description.abstract | Hypocretin-1 and hypocretin-2 are wake-promoting neuropeptides that are exclusively synthesized in the lateral hypothalamus. Hypocretin deficiency underlies the sleep disorder narcolepsy, which is characterized by excessive daytime sleepiness and disrupted nighttime sleep. In addition to hypocretin deficiency, narcoleptic patients display a reduction in GABA levels in the medial prefrontal cortex as compared to patients without narcolepsy, suggesting that GABA also plays a role in the pathophysiology of narcolepsy. The pontine reticular nucleus, oral part (PnO) is a key sleep-wake regulating brain region that is targeted by hypocretins and GABA. Microinjection of hypocretin-1 into the PnO increases wakefulness. Administration of hypocretin-1 to the PnO causes a concentration-dependent increase in GABA levels, and GABA in the PnO promotes wakefulness. The mechanisms by which hypocretin-1 increases wakefulness are not well understood. Therefore, the goal of my thesis research was to elucidate the mechanisms by which hypocretin-1 in the PnO causes an increase in wakefulness. I tested the hypothesis that hypocretin receptors in the PnO mediate the hypocretin-1-induced increase in wakefulness. Microinjection of hypocretin-1 into the PnO caused a concentration-dependent increase in wakefulness. Next I used the hypocretin receptor-1 antagonist SB-334867 and showed that the increase in wakefulness caused by hypocretin-1 was mediated by hypocretin receptors. I then tested whether the increase in wakefulness caused by hypocretin is dependent on GABAergic transmission. Indeed, I was able to show that the increase in wakefulness caused by administering hypocretin-1 to the PnO was blocked by the GABAA receptor antagonist bicuculline. My thesis research findings are the first to demonstrate that hypocretin-1 in the PnO promotes wakefulness by activating hypocretin receptors and GABAA receptors. Treatments for narcolepsy target the symptoms and not the pathophysiology of the disease, hypocretin deficiency. Because hypocretin-1 does not penetrate the blood-brain barrier it is important to develop drugs that target the downstream effectors of hypocretin. My thesis findings further our understanding of how hypocretin increases wakefulness and contribute to the rationale design of more selective drugs to treat narcolepsy. | en_US |
dc.format.extent | 1883029 bytes | |
dc.format.extent | 1373 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | en_US |
dc.subject | Hypocretin in the Pontine Nucleus, Oral Part | en_US |
dc.subject | Sleep | en_US |
dc.subject | Glutamate and Acetylcholine Release | en_US |
dc.title | Hypocretin-1 and GABA in the Pontine Reticular Formation Interact to Promote Wakefulness. | en_US |
dc.type | Thesis | en_US |
dc.description.thesisdegreename | PhD | en_US |
dc.description.thesisdegreediscipline | Pharmacology | en_US |
dc.description.thesisdegreegrantor | University of Michigan, Horace H. Rackham School of Graduate Studies | en_US |
dc.contributor.committeemember | Baghdoyan, Helen A. | en_US |
dc.contributor.committeemember | Fisher, Stephen K. | en_US |
dc.contributor.committeemember | Gnegy, Margaret E. | en_US |
dc.contributor.committeemember | Lydic, Ralph | en_US |
dc.contributor.committeemember | Woods, James H. | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbsecondlevel | Science (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/77843/1/hbrevig_1.pdf | |
dc.owningcollname | Dissertations and Theses (Ph.D. and Master's) |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.